Jafron Biomedical Co.,Ltd. focuses on the development, production, and commercialization of advanced biomaterials and medical devices, particularly within the blood purification and hemoadsorption sectors. The company provides essential solutions for a range of conditions, including kidney and liver diseases, critical illnesses such as sepsis, acute poisoning, and various autoimmune disorders. Their product portfolio encompasses innovative hemoperfusion cartridges, specialized blood purification machines like the DX-10 and Future F20, and adsorption columns targeting bilirubin and immune factors. With a strong emphasis on research and development, Jafron’s proprietary technologies are applied in over 8,000 hospitals across more than 90 countries and regions globally. Established in 1989, the company is headquartered in Zhuhai, China.